Advancing Cell Therapy Manufacturing
About
Cell therapies are advancing rapidly, yet moving from research-scale activity to clinical and commercial manufacturing remains a significant challenge. These therapies require specialised processes that can manage product variability, time-sensitive production, quality control and scalable manufacturing design.This event will examine the practical decisions that shape cell therapy manufacturing, from early process development through to clinical manufacturing readiness. Discussion will explore GMP operations, manufacturing platform selection, workflow efficiency, analytics, quality control, release testing and the factors that influence successful scale-up.
The program will also highlight Australia’s growing capability in cell therapy manufacturing and clinical translation, with a focus on collaboration between therapy developers, research institutions, clinical teams, technology providers and manufacturing partners. Through short presentations and expert discussion, delegates will gain insight into strengthening local capability and supporting the next generation of advanced cell therapy pipelines.
Date
Tuesday 23 June 2026 4:00 PM - 6:30 PM (UTC+10)Location
RSM
Level 27/120, Collins Street, Melbourne CBD Victoria 3000